Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,520.36
(
0.02%
)
US TECH 100
29,110.40
(
-0.23%
)
Dow Jones
50,644.28
(
0.36%
)
Brent Oil
93.85
(
1.52%
)
Bitcoin
73,298.99
(
-2.12%
)
News Focus
News Focus
Post# of 448111
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Larrybirdlegend

Send PM Follow Ignore
Followers 66
Posts 477
Boards Moderated 0
Alias Born 02/26/2019

Larrybirdlegend

Re: None

Friday, 08/09/2019 7:07:26 PM

Friday, August 09, 2019 7:07:26 PM

Post# of 448111
This from MRC on Twitter


https://pbs.twimg.com/media/EBiS28KUYAMRjrM.jpg


In his tweet says #2 is really the only debate. For those of you without Twitter, #2 is “safety and efficacy of Vascepa “

So, if that’s the core of the matter- it’s very fair to say safety and efficacy is incredibly strong.

Holding strong, and adding to position.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News